课题基金 / 基金详情

Can esomeprazole improve outcomes in women at high risk of pre-eclampsia? A Phase II placebo-controlled randomised, multi-centre clinical trial.

Can esomeprazole improve outcomes in women at high risk of pre-eclampsia? A Phase II placebo-controlled randomised, multi-centre clinical trial.
埃索美拉唑能否改善先兆子痫高危女性的预后?
批准号:
nhmrc : GNT1145585
负责人:
A/Pr Chiu Yee Liona Poon
金额:
$159.71万
依托单位:
依托单位国家:
澳大利亚
项目类别:
Project Grants
财政年份:
2018
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2018-01-01 至 --

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
先兆子痫,通过怀孕期间高血压的发展而被认识到,会导致母亲和婴儿的死亡和/或伤害。对先兆子痫发展的进一步了解为疾病的早期预测和预防提供了机会。我们将使用一个强大的预测模型来识别先兆子痫高危妊娠,然后观察一种新的治疗方法(埃索美拉唑)对母体血压和这种疾病的发展的影响。
英文摘要
Pre-eclampsia, recognised through the development of high blood pressure in pregnancy, causes death and/or injury to mothers and babies. An improved understanding of the development of pre-eclampsia has provided opportunities for early prediction and prevention of disease. We will use a powerful predictive model to identify pregnancies at high risk of pre-eclampsia then observe the effect of a novel treatment (esomeprazole) on maternal blood pressure and the development of this disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金